High-certainty evidence for protection in adolescent girls and young women aged 15 to 26 years
Clinicians using communication training and fact sheets to inform adolescents about HPV, significantly increased vaccination initiation and completion rates among their patients.
The importance of male vaccination cannot be overemphasized, because the risk of male-to-female HPV transmission is significant.
The researchers found that 2 doses of the HPV vaccine were just as protective as 3 doses.
Nitrate inhalants (poppers) associated with increased virus-associated cancer risk in HIV-uninfected MSMMay 22, 2017
Among HIV-uninfected men aged 50 to 70, heavy popper use was associated with an increased risk of virus-associated cancer with causes linked to HPV, HHV-8, and Epstein-Barr virus.
The data suggest that the vaccine may be reducing the prevalence of those infections by as high as 100%.
However, the HPV vaccine has the potential to reverse the epidemic and prevent thousands of cancers in the United States each year.
The students improved their basic knowledge of HPV and understood the benefits of the HPV vaccine.
Children younger than 15 may be given 2 HPV vaccine doses instead of 3, and the shots should be spaced at least 6 months apart.
A new HPV screening test that uses cervical cells collected for a Pap test has been approved by the FDA.
A greater understanding of the healthcare issues specific to the lesbian, gay, bisexual, and transgender community may improve the quality of care.
College-aged students may benefit from continued education regarding the spread of HPV, especially oral transmission
The new vaccine protects against 9 types of HPV and 5 cancer-causing strains.
The American Society of Clinical Oncology has released its recommendations to help improve rates of HPV vaccination worldwide.
Data collected between 2009 and 2012 show a significant decline in cases of HPV in females aged 14-19 and 20-24.
Confusion surrounds the current screening recommendations and guidelines.
A variety of factors have led to low rates of teenage boys being vaccinated for the human papillomavirus (HPV), said a report published in Pediatrics.
Human papillomavirus vaccination not linked to increase in sexually transmitted infections in adolescent femalesOctober 02, 2015
The HPV vaccination is not associated with an increase in sexually transmitted infections in adolescent females, study results suggest. The vaccine is recommended for all children 11 to 12 years old.
The Cervarix vaccine may be as effective in one or two doses as it is with three.
In survey, more than half didn't get vaccinated; many were unaware of risk
While not statistically significant, participants who noted they had received the HPV vaccine also reported that they used condoms without fail at every sexual encounter.
The potential costs and effectiveness of HPV4 vaccination versus no vaccination were compared in a theoretical cohort based on a cohort of 192,940 boys aged 12 years.
The CDC's Advisory Committee on Immunization Practices met to vote on updates to several vaccine recommendations, including for HPV.
Almost half of American girls receive the HPV vaccine after the recommended age.
In a survey conducted by the Advisory Committee on Immunization Practices (ACIP), 33% of clinicians routinely recommend the HPV4 vaccine to 11- and 12-year-old males.
The cobas HPV test detects DNA from 14 types of HPV and included types 16 and 18, which cause 70% of cervical cancers.
In primary and secondary analyses, vaccination was not associated with an increased risk of multiple sclerosis or other demyelinating diseases.
Having female sex partner with HPV puts men at greater risk for contracting HPV type responsible for throat cancers.
One third of women aged 15 to 26 years with precancerous cervical lesions were infected with more than one type of HPV.
After surveying low-income communities, researchers found that human papillomavirus knowledge did not sway vaccination compliance.